Mark Mortenson - 04 Nov 2021 Form 4 Insider Report for Clene Inc. (CLNN)

Role
Chief Science Officer
Signature
/s/ Jerry Miraglia POA
Issuer symbol
CLNN
Transactions as of
04 Nov 2021
Transactions value $
$0
Form type
4
Filing time
05 Nov 2021, 18:14:20 UTC
Previous filing
01 Jul 2021
Next filing
16 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLNN Stock Options (Right to buy) Award $0 +200,000 $0 200,000 04 Nov 2021 Common Stock 200,000 $4.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on November 4, 2021 as an option for 200,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $4.74 per share. The options vest with respect to the first 25% of such shares on November 4, 2022 and then in 36 equal installments of Common Stock on the last day of each calendar month, beginning November 30, 2022, until such shares are fully vested